Wesana Health Holdings Inc. (CNSX: WESA.X)
Health Care · Pharmaceuticals · US
CA$—
— today · — 1Y
Wesana Health Holdings Inc. (CNSX: WESA.X) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $251.48K.
trading between 0.01 and 0.04.
Tweenvest scores Wesana Health Holdings Inc. across four factors: quality 9/100. Its strongest factor is quality.
WESA.X price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $251.48K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- -0.70
- 52-week high
- CA$0.04
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 34.96M
- Employees
- —
- Next earnings
- —
About Wesana Health Holdings Inc.
Wesana Health Holdings Inc, a life sciences company, engages in the development and delivery of psychedelic medicines and psilocybin-assisted psychotherapies to treat traumatic brain injuries. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is headquartered in Chicago, Illinois.
- Listed since
- May 10, 2021
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,237.51 | -1.43% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.29 | +0.76% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.48 | -1.36% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.89 | -0.64% |
Figures last refreshed Aug 18, 2026.